Innate Pharma S.A. GAAP EPS of -Euro0.25, revenue of Euro4.9M
Source: SeekingAlpha
2025-09-17 14:45:13 ET
More on Innate Pharma
- Innate Pharma S.A. (IPHA) Q2 2025 Earnings Call Transcript
- Innate Pharma S.A. 2025 Q2 - Results - Earnings Call Presentation
- Seeking Alpha’s Quant Rating on Innate Pharma
- Historical earnings data for Innate Pharma
- Financial information for Innate Pharma
Read the full article on Seeking Alpha
For further details see:
Innate Pharma S.A. GAAP EPS of -€0.25, revenue of €4.9M
Innate Pharma - Class A
NASDAQ: IPHYF
IPHYF Trading
-63.76% G/L:
$2.155 Last:
100 Volume:
$2.155 Open:
IPHYF Latest News
February 19, 2026 01:00:00 am
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
February 18, 2026 01:00:00 am
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
December 22, 2025 01:00:00 am
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
IPHYF Stock Data
$160,353,438
44,923,628
N/A
20
N/A
Biotechnology & Life Sciences
Healthcare
FR
Marseille
